<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03109951</url>
  </required_header>
  <id_info>
    <org_study_id>IS16OASI0026</org_study_id>
    <nct_id>NCT03109951</nct_id>
  </id_info>
  <brief_title>Abnormal Blood Sugar Tests in Diabetic Patients During Colonoscopy Preparation</brief_title>
  <official_title>Abnormal Blood Sugar Tests in Diabetic Patients During Colonoscopy Preparation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catholic Kwandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Catholic Kwandong University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Type 2 diabetes is rapidly increasing globally and has been associated with an increased risk
      of colorectal cancer. Therefore, the numbers of diabetic patients who will undergo
      colonoscopic screening are expected to grow exponentially. Colonoscopic preparation entails
      prolonged fasting, cessation of anti-diabetic medication and ingestion of preparation
      medications. This may put the diabetic patient at risk of potentially dangerous hypo- or
      hyperglycemia. However, studies regarding the safety of colonoscopic preparation in diabetic
      are lacking. In this study, the investigators aim to discover the prevalence of abnormal
      glucose levels in diabetic patients who undergo colonoscopy. The investigators also aim to
      find out risk factors for abnormal glucose levels and develop a safe preparation protocol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Type 2 diabetes subjects who will undergo colonoscopy will be prospectively enrolled
           when visiting the outpatient clinic.

        2. Subjects will be instructed to fast from 6pm of the day before colonoscopy.

        3. Subjects will be instructed to abstain from diabetes medication while the subjects fast.

        4. Subjects who are scheduled to undergo colonoscopy in the morning will take colonoscopy
           preparation medication (2L (liter) of polyethylene glycol with ascorbic acid) in a split
           dose (i.e. 1L from 8-10 pm of the day before colonoscopy and 1L 4-6 hours before
           colonoscopy). Those who will undergo colonoscopy in the afternoon will take 2L of the
           preparation medication 6 hours before colonoscopy.

        5. Subjects will be instructed to take the preparation medication at rate of 250 mL every
           10 to 15 minutes.

        6. Upon arrival at the endoscopy center of International St. Mary's hospital, subjects will
           be given a self-administered questionnaire which will ask about their age, gender,
           duration of diabetes, type of diabetes medication, time of last diabetes medication
           taken, knowledge of hypo/hyperglycemia symptoms, previous hypo/hyperglycemia experience,
           self-treatment of hypoglycemia (if done), total amount of colonoscopy preparation
           medication ingested, total fasting time and time of last preparation medication
           ingested.

        7. Subjects will have vital signs (blood pressure, heart rate) taken and their capillary
           glucose levels checked using the Accu-Chek Performa.

        8. Any subjects with capillary glucose levels &lt;70mg/dL or &gt;250mg/dL will be reported to the
           attending physician. Those with an initial glucose level &lt;70mg/dL will be given a piece
           of candy and have their glucose rechecked in 10 mins. Subjects will be asked if the
           hypoglycemic symptoms (if any) have abated. Those with a glucose level &gt;250mg/dL will
           undergo hydration with normal saline at 120 ml/Hr. Those who do not respond to treatment
           or are in critical condition will be moved to the Emergency department for treatment.
           Subjects who respond to treatment will have their glucose levels checked after
           colonoscopy before undergoing discharge. Those with abnormal levels upon follow-up
           testing will be sent to either the endocrinology outpatient clinic or the emergency room
           depending on their clinical severity.

        9. All data will be recorded by initials with patient identities masked. All data will be
           kept in a locked and secure location by the principal investigator.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 25, 2017</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Single group</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Open label</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Abnormal Glucose Levels After Colonoscopic Preparation</measure>
    <time_frame>30 minutes before colonoscopy</time_frame>
    <description>Count of patients with Serum glucose levels &lt; 70mg/dL or &gt;250mg/dL</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognition of Hypoglycemic Symptoms</measure>
    <time_frame>30 minutes before colonoscopy</time_frame>
    <description>Subjects awareness of hypoglycemic symptoms - by questionnaire 96 subjects were aware of hypoglycemic symptoms and could recognize them.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Self-treatment and Relief of Hypoglycemic Symptoms</measure>
    <time_frame>From colonoscopy preparation beginning to day 1 after colonoscopy</time_frame>
    <description>Discover if self-treatment of hypoglycemic symptoms relieves hypoglycemia and associated symptoms</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">187</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <condition>Colonoscopy</condition>
  <arm_group>
    <arm_group_label>Diabetes group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Type 2 diabetes patients undergoing colonoscopy with preparation with 2L of polyethylene glycol.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Colonoscopy preparation using polyethylene glycol</intervention_name>
    <description>Colonoscopy preparation using standard preparation with 2L of polyethylene glycol.</description>
    <arm_group_label>Diabetes group</arm_group_label>
    <other_name>Have not taken diabetes medication since 6pm of the day before colonoscopy.</other_name>
    <other_name>Have fasted since 6pm of the day before colonoscopy.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetes

          -  Between ages of 20-75

          -  Undergo colonoscopy at International St. Mary's Hospital

        Exclusion Criteria:

          -  Type 1 diabetes patients

          -  Did not undergo colonoscopy preparation

          -  Did not meet fasting requirements

          -  Have known current infectious diseases

          -  Have known cancer and/or are under cancer treatment

          -  Are under intravenous fluid therapy during colonoscopy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Myong Ki Baeg, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>International St. Mary's Hospital, Catholic Kwandong University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>International St.Mary's Hospital</name>
      <address>
        <city>Incheon</city>
        <zip>22711</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Vann MA. Perioperative management of ambulatory surgical patients with diabetes mellitus. Curr Opin Anaesthesiol. 2009 Dec;22(6):718-24. doi: 10.1097/ACO.0b013e3283310f51. Review.</citation>
    <PMID>19696663</PMID>
  </reference>
  <reference>
    <citation>Kollarits CR, Kendrick RM, Guess M. Perioperative treatment of patients with diabetes having eye surgery with local anesthesia in an ambulatory facility. Ophthalmic Surg Lasers Imaging. 2004 May-Jun;35(3):185-8.</citation>
    <PMID>15185785</PMID>
  </reference>
  <reference>
    <citation>Joshi GP, Chung F, Vann MA, Ahmad S, Gan TJ, Goulson DT, Merrill DG, Twersky R; Society for Ambulatory Anesthesia. Society for Ambulatory Anesthesia consensus statement on perioperative blood glucose management in diabetic patients undergoing ambulatory surgery. Anesth Analg. 2010 Dec;111(6):1378-87. doi: 10.1213/ANE.0b013e3181f9c288. Epub 2010 Oct 1. Review.</citation>
    <PMID>20889933</PMID>
  </reference>
  <reference>
    <citation>Yao J, Zhang W, Chen J, Zhang G, Zheng S. Enteral nutrition before bowel preparation improves the safety of colonoscopy in the elderly. Turk J Gastroenterol. 2013;24(5):400-5.</citation>
    <PMID>24557963</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 3, 2017</study_first_submitted>
  <study_first_submitted_qc>April 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2017</study_first_posted>
  <results_first_submitted>January 24, 2020</results_first_submitted>
  <results_first_submitted_qc>March 6, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">March 20, 2020</results_first_posted>
  <last_update_submitted>March 6, 2020</last_update_submitted>
  <last_update_submitted_qc>March 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Catholic Kwandong University</investigator_affiliation>
    <investigator_full_name>Myong Ki Baeg</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>Type 2 diabetes</keyword>
  <keyword>colonoscopy</keyword>
  <keyword>hypoglycemia</keyword>
  <keyword>hyperglycemia</keyword>
  <keyword>polyethylene glycol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 2, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/51/NCT03109951/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 2, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/51/NCT03109951/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>None noted as this was a single-arm study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Diabetes Group</title>
          <description>Type 2 diabetes patients undergoing colonoscopy with preparation with 2L of polyethylene glycol.
Colonoscopy preparation using polyethylene glycol: Colonoscopy preparation using standard preparation with 2L of polyethylene glycol.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="187"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="187"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Diabetes Group</title>
          <description>Type 2 diabetes patients undergoing colonoscopy with preparation with 2L of polyethylene glycol.
Colonoscopy preparation using polyethylene glycol: Colonoscopy preparation using standard preparation with 2L of polyethylene glycol.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="187"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59.5" spread="9.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Korean Ethnicity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="187"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>South Korea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="187"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fasting glucose level</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="135.9" spread="33.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of polyps</title>
          <units>polyps</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.3" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of adenomas</title>
          <units>adenomas</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.1" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of advanced adenomas</title>
          <units>advanced adenomas</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.2" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes history</title>
          <description>Previous Diabetes history before study enrollment.</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.3" spread="7.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fasting period</title>
          <description>Time(hours) from last meal intake to colonoscopy start.</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19.2" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Abnormal Glucose Levels After Colonoscopic Preparation</title>
        <description>Count of patients with Serum glucose levels &lt; 70mg/dL or &gt;250mg/dL</description>
        <time_frame>30 minutes before colonoscopy</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Diabetes Group</title>
            <description>Type 2 diabetes patients undergoing colonoscopy with preparation with 2L of polyethylene glycol.
Colonoscopy preparation using polyethylene glycol: Colonoscopy preparation using standard preparation with 2L of polyethylene glycol.</description>
          </group>
        </group_list>
        <measure>
          <title>Abnormal Glucose Levels After Colonoscopic Preparation</title>
          <description>Count of patients with Serum glucose levels &lt; 70mg/dL or &gt;250mg/dL</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="187"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Number of hyperglycemia subjects</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Number of hypoglycemia subjects</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Number of subjects without hypo or hyperglycemia</title>
                  <measurement_list>
                    <measurement group_id="O1" value="185"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cognition of Hypoglycemic Symptoms</title>
        <description>Subjects awareness of hypoglycemic symptoms - by questionnaire 96 subjects were aware of hypoglycemic symptoms and could recognize them.</description>
        <time_frame>30 minutes before colonoscopy</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Diabetes Group</title>
            <description>Type 2 diabetes patients undergoing colonoscopy with preparation with 2L of polyethylene glycol.
Colonoscopy preparation using polyethylene glycol: Colonoscopy preparation using standard preparation with 2L of polyethylene glycol.</description>
          </group>
        </group_list>
        <measure>
          <title>Cognition of Hypoglycemic Symptoms</title>
          <description>Subjects awareness of hypoglycemic symptoms - by questionnaire 96 subjects were aware of hypoglycemic symptoms and could recognize them.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="187"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Self-treatment and Relief of Hypoglycemic Symptoms</title>
        <description>Discover if self-treatment of hypoglycemic symptoms relieves hypoglycemia and associated symptoms</description>
        <time_frame>From colonoscopy preparation beginning to day 1 after colonoscopy</time_frame>
        <population>4 subjects reported hypoglycemia symptoms. All recovered through self-treatment (e.g. drinking juice or taking candy).</population>
        <group_list>
          <group group_id="O1">
            <title>Diabetes Group</title>
            <description>Type 2 diabetes patients undergoing colonoscopy with preparation with 2L of polyethylene glycol.
Colonoscopy preparation using polyethylene glycol: Colonoscopy preparation using standard preparation with 2L of polyethylene glycol.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Self-treatment and Relief of Hypoglycemic Symptoms</title>
          <description>Discover if self-treatment of hypoglycemic symptoms relieves hypoglycemia and associated symptoms</description>
          <population>4 subjects reported hypoglycemia symptoms. All recovered through self-treatment (e.g. drinking juice or taking candy).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="187"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected for 1 month.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Diabetes Group</title>
          <description>Type 2 diabetes patients undergoing colonoscopy with preparation with 2L of polyethylene glycol.
Colonoscopy preparation using polyethylene glycol: Colonoscopy preparation using standard preparation with 2L of polyethylene glycol.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="187"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="187"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="187"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Smaller number of subjects than anticipated due to poor enrollment.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Myong Ki Baeg</name_or_title>
      <organization>International St. Mary's Hospital, Catholic Kwandong University</organization>
      <phone>82-10-6391-9010</phone>
      <email>baegmk@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

